v v v v v v v
Jacquelyn L. Banasik Chapter 1-54-Grades A+-2025-
v v v v v v
2024 v
Chapter 01: Introduction to Pathophysiology
v v v v
Banasik: Pathophysiology, 7th Edition
v v v v
MULTIPLE vCHOICE
1. C.Q. vwas vrecently vexposed vto vgroup vA vhemolytic vStreptococcus vand vsubsequently vdeveloped
va vpharyngeal vinfection. vHis vclinic vexamination vreveals van voral vtemperature vof v102.3°F, vskin
vrash, vdysphagia, vand vreddened vthroat vmucosa vwith vmultiple vpustules. vHe vcomplains vof vsore
vthroat, vmalaise, vand vjoint vstiffness. vA vthroat vculture vis vpositive vfor vStreptococcus, vand
vantibiotics vhave vbeen vprescribed. vThe vetiology vof vC.Q.’s vdisease vis
a. a vsore vthroat.
b. streptococcal vinfection.
c. genetic vsusceptibility.
d. pharyngitis.
ANS: v B
Etiology vrefers vto vthe vproposed vcause vor vcauses vof va vparticular vdisease vprocess. vA vsore vthroat
vis vthe vmanifestation vof vthe vdisease vprocess. vGenetic vsusceptibility vrefers vto vinherited
vtendency vto vdevelop va vdisease. vPharyngitis vrefers vto vinflammation vof vthe vthroat vand vis valso va
vclinical vmanifestation vof vthe vdisease vprocess.
2. A v17-year-old vcollege-bound vstudent vreceives va vvaccine vagainst van vorganism vthat
causes vmeningitis. vThis vis van vexample vof
v
a. primary vprevention.
b. secondary vprevention.
c. tertiary vprevention.
d. disease vtreatment.
ANS: v A
Primary vprevention vis vprevention vof vdisease vby valtering vsusceptibility vor vreducing vexposure
vfor vsusceptible vindividuals, vin vthis vcase vby vproviding vvaccination. vSecondary vprevention vis
vthe vearly vdetection, vscreening, vand vmanagement vof vthe vdisease. vTertiary vprevention vincludes
vrehabilitative vand vsupportive vcare vand vattempts vto valleviate vdisability vand vrestore veffective
vfunctioning. vDisease vtreatment vinvolves vmanagement vof vthe vdisease vonce vit vhas vdeveloped.
3. An vobese vbut votherwise vhealthy vteen vis vgiven va vprescription vfor va vlow-calorie vdiet vand
exercise vprogram. vThis vis van vexample vof
v
a. primary vprevention.
b. secondary vprevention.
c. tertiary vprevention.
d. disease vtreatment.
ANS: v B
Secondary vprevention vis vthe vearly vdetection, vscreening, vand vmanagement vof vthe vdisease vsuch
vas vprescribing vdiet vand vexercise vfor van vindividual vwho vhas valready vdeveloped vobesity.
vPrimary vprevention vis vprevention vof vdisease vby valtering vsusceptibility vor vreducing vexposure
,vfor vsusceptible vindividuals. vTertiary vprevention vincludes vrehabilitative vand vsupportive vcare
vand vattempts vto valleviate vdisability vand vrestore veffective vfunctioning. vDisease vtreatment
vinvolves vmanagement vof vthe vdisease vonce vit vhas vdeveloped.
, 4. A vpatient vwith vhigh vblood vpressure vwho vis votherwise vhealthy vis vcounseled vto vrestrict
sodium vintake. vThis vis van vexample vof
v
a. primary vprevention.
b. secondary vprevention.
c. tertiary vprevention.
d. disease vtreatment.
ANS: v B
Secondary vprevention vis vthe vearly vdetection, vscreening, vand vmanagement vof vthe vdisease,
vsuch vas vby vprescribing vsodium vrestriction vfor vhigh vblood vpressure. vPrimary vprevention vis
vprevention vof vdisease vby valtering vsusceptibility vor vreducing vexposure vfor vsusceptible
vindividuals. vTertiary vprevention vincludes vrehabilitative vand vsupportive vcare vand vattempts vto
valleviate vdisability vand vrestore veffective vfunctioning. vDisease vtreatment vinvolves
vmanagement vof vthe vdisease vonce vit vhas vdeveloped.
5. After vsuffering va vheart vattack, va vmiddle-aged vman vis vcounseled vto vtake va vcholesterol-
lowering vmedication. vThis vis van vexample vof
a. primary vprevention.
b. secondary vprevention.
c. tertiary vprevention.
d. disease vtreatment.
ANS: v C
Tertiary vprevention vincludes vrehabilitative vand vsupportive vcare vand vattempts vto valleviate
vdisability vand vrestore veffective vfunctioning vsuch vas vprescribing va vcholesterol-lowering
vmedication vfollowing va vheart vattack. vPrimary vprevention vis vprevention vof vdisease vby valtering
vsusceptibility vor vreducing vexposure vfor vsusceptible vindividuals. vSecondary vprevention vis vthe
vearly vdetection, vscreening, vand vmanagement vof vthe vdisease. vDisease vtreatment vinvolves
vmanagement vof vthe vdisease vonce vit vhas vdeveloped.
6. A vpatient vhas vbeen vexposed vto vmeningococcal vmeningitis, vbut vis vnot vyet vdemonstrating vsigns
of vthis vdisease. vThis vstage vof villness vis vcalled vthe
v stage.
a. prodromal
b. latent
c. sequela
d. convalescence
ANS: v B
Incubation vrefers vto vthe vinterval vbetween vexposure vof va vtissue vto van vinjurious vagent vand vthe
vfirst vappearance vof vsigns vand vsymptoms. vIn vinfectious vdiseases, vthis vperiod vis voften vcalled
vthe vincubation v(latent) vperiod. vProdromal vrefers vto vthe vappearance vof vthe vfirst vsigns vand
vsymptoms vindicating vthe vonset vof va vdisease. vThese vare voften vnonspecific, vsuch vas vheadache,
vmalaise, vanorexia, vand vnausea, vwhich vare vassociated vwith va vnumber vof vdifferent vdiseases.
vSequela vrefers vto vsubsequent vpathologic vcondition vresulting vfrom va vdisease. vConvalescence
vis vthe vstage vof vrecovery vafter va vdisease, vinjury, vor vsurgical voperation.
7. A vdisease vthat vis vnative vto va vparticular vregion vis vcalled
a. epidemic.
b. endemic.
c. pandemic.
d. ethnographic.